167 filings
Page 8 of 9
6-K
y9wgpj2di r5woj
19 Feb 21
Immunoprecise Antibodies LTD. 6-K
7:30am
6-K
fd5diacl0dnop7b967
11 Feb 21
IPA Announces Closing of Over-Allotment Option Associated with the Recently Completed Bought Deal Offering of Common Shares
12:00am
6-K
j4otzqs8vip7f hr
8 Feb 21
IPA Announces Closing of $21.7 Million Bought Deal Offering of Common Shares
4:35pm
6-K
z95m 3s15t
4 Feb 21
Amended and Restated Underwriting Agreement
5:12pm
SUPPL
j7y5yt10ic
4 Feb 21
Supplemental materials (foreign)
5:08pm
FWP
2wb14wu halct
4 Feb 21
Free writing prospectus
12:00am
FWP
v33dywyp
3 Feb 21
Free writing prospectus
9:59pm
SUPPL
lxtjjzh7ktt2 ivgn8t
3 Feb 21
Supplemental materials (foreign)
4:42pm
6-K
n0f0rnj
3 Feb 21
Condensed Interim Consolidated Financial Statements
4:28pm
EFFECT
plfpqfzpgqovfwy
12 Jan 21
Notice of effectiveness
12:15am
6-K
ugm45h0svj7
7 Jan 21
Immunoprecise Antibodies LTD. 6-K
8:56am
6-K
dmjh3d3ld8mkkdadf5
6 Jan 21
Immunoprecise Antibodies LTD. 6-K
8:00am
F-10/A
1rp1 yi6xrhgc
5 Jan 21
Registration of securities (Canada) (amended)
5:29pm
6-K
32cus0b
30 Dec 20
Immunoprecise Antibodies LTD. 6-K
3:27pm
SEC STAFF ACTION
azts30y5
29 Dec 20
SEC staff action: Order
2:38pm
40FR12B/A
jfzkyxy
28 Dec 20
Initial registration of securities (Canada) (amended)
4:02pm
CERT
8flklo
28 Dec 20
Certification of approval for exchange listing
10:18am
40FR12B/A
a39rxvu35
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am
F-X
gfvy85dpgdke
9 Nov 20
Appointment of agent for service of process by issuers registering securities
8:39am
F-10
s3xw58l5hmc7u9mto
9 Nov 20
Registration of securities (Canada)
8:18am